The Role of the Immune System in Metabolic Health and Disease

Cell Metabolism

Volumn 25, Issue 3, 2017, Pages 506-521

  Zmora, Niv ^a,b,c   Bashiardes, Stavros ^a   Levy, Maayan ^a   Elinav, Eran ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

diabetes mellitus; immunity; malnutrition; metabolism; microbiome; microbiota; nutrition; obesity

Indexed keywords

ADAPTATION; AGING; CACHEXIA; DIET RESTRICTION; ENVIRONMENT; EPIGENETICS; GENE INTERACTION; HOMEOSTASIS; HOST; HUMAN; IMMUNE SYSTEM; MALNUTRITION; META ANALYSIS (TOPIC); METABOLIC DISORDER; METABOLIC REGULATION; METABOLIC SYNDROME X; MICROBIOME; NEWBORN PERIOD; NONHUMAN; NUTRITION; OBESITY; PREGNANCY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STARVATION; ANIMAL; BIOLOGICAL MODEL; GENETICS; HEALTH; IMMUNOLOGY; MICROFLORA; PHYSIOLOGY; TRANSLATIONAL RESEARCH;

AGING; ANIMALS; HEALTH; HUMANS; METABOLIC DISEASES; MICROBIOTA; MODELS, BIOLOGICAL; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85014512644     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2017.02.006     Document Type: Review

References (203)

1. Ahmadian, M., Suh, J.M., Hah, N., Liddle, C., Atkins, A.R., Downes, M., Evans, R.M., PPARγ signaling and metabolism: the good, the bad and the future. Nat. Med. 19 (2013), 557–566.
2. Ali, M.A., Strandvik, B., Palme-Kilander, C., Yngve, A., Lower polyamine levels in breast milk of obese mothers compared to mothers with normal body weight. J. Hum. Nutr. Diet. 26:Suppl 1 (2013), 164–170.
3. Aoyama, M., Kotani, J., Usami, M., Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition 26 (2010), 653–661.
4. Arkan, M.C., Hevener, A.L., Greten, F.R., Maeda, S., Li, Z.-W., Long, J.M., Wynshaw-Boris, A., Poli, G., Olefsky, J., Karin, M., IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005), 191–198.
5. Arora, P., Garcia-Bailo, B., Dastani, Z., Brenner, D., Villegas, A., Malik, S., Spector, T.D., Richards, B., El-Sohemy, A., Karmali, M., Badawi, A., Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med. Genet., 12, 2011, 95.
6. Bäckhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F., Gordon, J.I., The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101 (2004), 15718–15723.
7. Baeck, C., Wehr, A., Karlmark, K.R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 61 (2012), 416–426.
8. Barker, D.J., In utero programming of chronic disease. Clin. Sci. 95 (1998), 115–128.
9. Basu, S., Haghiac, M., Surace, P., Challier, J.-C., Guerre-Millo, M., Singh, K., Waters, T., Minium, J., Presley, L., Catalano, P.M., Hauguel-de Mouzon, S., Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 19 (2011), 476–482.
10. Berndt, B.E., Zhang, M., Owyang, S.Y., Cole, T.S., Wang, T.W., Luther, J., Veniaminova, N.A., Merchant, J.L., Chen, C.-C., Huffnagle, G.B., Kao, J.Y., Butyrate increases IL-23 production by stimulated dendritic cells. Am. J. Physiol. Gastrointest. Liver Physiol. 303 (2012), G1384–G1392.
11. Bhargava, P., Li, C., Stanya, K.J., Jacobi, D., Dai, L., Liu, S., Gangl, M.R., Harn, D.A., Lee, C.-H., Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways. Nat. Med. 18 (2012), 1665–1672.
12. Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkïla, J., Monti, D., Satokari, R., Franceschi, C., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE, 5, 2010, e10667.
13. Blanton, L.V., Charbonneau, M.R., Salih, T., Barratt, M.J., Venkatesh, S., Ilkaveya, O., Subramanian, S., Manary, M.J., Trehan, I., Jorgensen, J.M., et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science, 351, 2016, aad3311.
14. Bobbert, T., Rochlitz, H., Wegewitz, U., Akpulat, S., Mai, K., Weickert, M.O., Möhlig, M., Pfeiffer, A.F.H., Spranger, J., Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 54 (2005), 2712–2719.
15. Böttcher, M.F., Jenmalm, M.C., Garofalo, R.P., Björkstén, B., Cytokines in breast milk from allergic and nonallergic mothers. Pediatr. Res. 47 (2000), 157–162.
16. Boyd, S.D., Jackson, K.J.L., Predicting vaccine responsiveness. Cell Host Microbe 17 (2015), 301–307.
17. Brandhorst, S., Choi, I.Y., Wei, M., Cheng, C.W., Sedrakyan, S., Navarrete, G., Dubeau, L., Yap, L.P., Park, R., Vinciguerra, M., et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metab. 22 (2015), 86–99.
18. Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E.K., Calkin, A.C., Brownlee, M., Cooper, M.E., El-Osta, A., Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58 (2009), 1229–1236.
19. Brodin, P., Jojic, V., Gao, T., Bhattacharya, S., Angel, C.J.L., Furman, D., Shen-Orr, S., Dekker, C.L., Swan, G.E., Butte, A.J., et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 160 (2015), 37–47.
20. Brown, E.M., Wlodarska, M., Willing, B.P., Vonaesch, P., Han, J., Reynolds, L.A., Arrieta, M.-C., Uhrig, M., Scholz, R., Partida, O., et al. Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat. Commun., 6, 2015, 7806.
21. Bruce, D., Cantorna, M.T., Intrinsic requirement for the vitamin D receptor in the development of CD8αα-expressing T cells. J. Immunol. 186 (2011), 2819–2825.
22. Brumbaugh, D.E., Friedman, J.E., Developmental origins of nonalcoholic fatty liver disease. Pediatr. Res. 75 (2014), 140–147.
23. Cai, D., Yuan, M., Frantz, D.F., Melendez, P.A., Hansen, L., Lee, J., Shoelson, S.E., Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11 (2005), 183–190.
24. Caldefie-Chezet, F., Poulin, A., Tridon, A., Sion, B., Vasson, M.P., Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action?. J. Leukoc. Biol. 69 (2001), 414–418.
25. Calle, E.E., Kaaks, R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4 (2004), 579–591.
26. Campbell, D.I., Murch, S.H., Elia, M., Sullivan, P.B., Sanyang, M.S., Jobarteh, B., Lunn, P.G., Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function. Pediatr. Res. 54 (2003), 306–311.
27. Cancello, R., Tordjman, J., Poitou, C., Guilhem, G., Bouillot, J.L., Hugol, D., Coussieu, C., Basdevant, A., Bar Hen, A., Bedossa, P., et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55 (2006), 1554–1561.
28. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., Burcelin, R., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
29. Carr, E.J., Dooley, J., Garcia-Perez, J.E., Lagou, V., Lee, J.C., Wouters, C., Meyts, I., Goris, A., Boeckxstaens, G., Linterman, M.A., Liston, A., The cellular composition of the human immune system is shaped by age and cohabitation. Nat. Immunol. 17 (2016), 461–468.
30. Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M.A., Kurz-Levin, M., Zayed, H., Solinger, A.M., Mandrup-Poulsen, T., Dinarello, C.A., Donath, M.Y., Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35 (2012), 1654–1662.
31. Challier, J.C., Basu, S., Bintein, T., Minium, J., Hotmire, K., Catalano, P.M., Hauguel-de Mouzon, S., Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 29 (2008), 274–281.
32. Charbonneau, M.R., O'Donnell, D., Blanton, L.V., Totten, S.M., Davis, J.C.C., Barratt, M.J., Cheng, J., Guruge, J., Talcott, M., Bain, J.R., et al. Sialylated Milk Oligosaccharides Promote Microbiota-Dependent Growth in Models of Infant Undernutrition. Cell 164 (2016), 859–871.
33. Chen, Y., Chou, K., Fuchs, E., Havran, W.L., Boismenu, R., Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc. Natl. Acad. Sci. USA 99 (2002), 14338–14343.
34. Chen, S., Sims, G.P., Chen, X.X., Gu, Y.Y., Chen, S., Lipsky, P.E., Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 179 (2007), 1634–1647.
35. Chen, Y., Zhu, J., Lum, P.Y., Yang, X., Pinto, S., MacNeil, D.J., Zhang, C., Lamb, J., Edwards, S., Sieberts, S.K., et al. Variations in DNA elucidate molecular networks that cause disease. Nature 452 (2008), 429–435.
36. Cheng, C.W., Adams, G.B., Perin, L., Wei, M., Zhou, X., Lam, B.S., Da Sacco, S., Mirisola, M., Quinn, D.I., Dorff, T.B., et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell 14 (2014), 810–823.
37. Cho, I., Yamanishi, S., Cox, L., Methé, B.A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488 (2012), 621–626.
38. Cho, C.E., Taesuwan, S., Malysheva, O.V., Bender, E., Tulchinsky, N.F., Yan, J., Sutter, J.L., Caudill, M.A., Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial. Mol. Nutr. Food Res., 61, 2017, 10.1002/mnfr.201600324 Published online August 3, 2016.
39. Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S.E., Benoist, C., Mathis, D., PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486 (2012), 549–553.
40. Claesson, M.J., Jeffery, I.B., Conde, S., Power, S.E., O'Connor, E.M., Cusack, S., Harris, H.M.B., Coakley, M., Lakshminarayanan, B., O'Sullivan, O., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–184.
41. Clark, R.I., Tan, S.W.S., Péan, C.B., Roostalu, U., Vivancos, V., Bronda, K., Pilátová, M., Fu, J., Walker, D.W., Berdeaux, R., et al. MEF2 is an in vivo immune-metabolic switch. Cell 155 (2013), 435–447.
42. Clark, R.I., Salazar, A., Yamada, R., Fitz-Gibbon, S., Morselli, M., Alcaraz, J., Rana, A., Rera, M., Pellegrini, M., Ja, W.W., Walker, D.W., Distinct Shifts in Microbiota Composition during Drosophila Aging Impair Intestinal Function and Drive Mortality. Cell Rep. 12 (2015), 1656–1667.
43. Collado, M.C., Laitinen, K., Salminen, S., Isolauri, E., Maternal weight and excessive weight gain during pregnancy modify the immunomodulatory potential of breast milk. Pediatr. Res. 72 (2012), 77–85.
44. Cox, L.M., Yamanishi, S., Sohn, J., Alekseyenko, A.V., Leung, J.M., Cho, I., Kim, S.G., Li, H., Gao, Z., Mahana, D., et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158 (2014), 705–721.
45. Dalmas, E., Venteclef, N., Caer, C., Poitou, C., Cremer, I., Aron-Wisnewsky, J., Lacroix-Desmazes, S., Bayry, J., Kaveri, S.V., Clément, K., et al. T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes 63 (2014), 1966–1977.
46. Deiuliis, J., Shah, Z., Shah, N., Needleman, B., Mikami, D., Narula, V., Perry, K., Hazey, J., Kampfrath, T., Kollengode, M., et al. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS ONE, 6, 2011, e16376.
47. Després, J.-P., Lemieux, I., Abdominal obesity and metabolic syndrome. Nature 444 (2006), 881–887.
48. DiAngelo, J.R., Bland, M.L., Bambina, S., Cherry, S., Birnbaum, M.J., The immune response attenuates growth and nutrient storage in Drosophila by reducing insulin signaling. Proc. Natl. Acad. Sci. USA 106 (2009), 20853–20858.
49. DiGiulio, D.B., Callahan, B.J., McMurdie, P.J., Costello, E.K., Lyell, D.J., Robaczewska, A., Sun, C.L., Goltsman, D.S.A., Wong, R.J., Shaw, G., et al. Temporal and spatial variation of the human microbiota during pregnancy. Proc. Natl. Acad. Sci. USA 112 (2015), 11060–11065.
50. Donath, M.Y., Shoelson, S.E., Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11 (2011), 98–107.
51. Dutchak, P.A., Katafuchi, T., Bookout, A.L., Choi, J.H., Yu, R.T., Mangelsdorf, D.J., Kliewer, S.A., Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell 148 (2012), 556–567.
52. Eisenberg, T., Knauer, H., Schauer, A., Büttner, S., Ruckenstuhl, C., Carmona-Gutierrez, D., Ring, J., Schroeder, S., Magnes, C., Antonacci, L., et al. Induction of autophagy by spermidine promotes longevity. Nat. Cell Biol. 11 (2009), 1305–1314.
53. Endres, S., Ghorbani, R., Kelley, V.E., Georgilis, K., Lonnemann, G., van der Meer, J.W., Cannon, J.G., Rogers, T.S., Klempner, M.S., Weber, P.C., et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 320 (1989), 265–271.
54. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 110 (2013), 9066–9071.
55. Fagarasan, S., Muramatsu, M., Suzuki, K., Nagaoka, H., Hiai, H., Honjo, T., Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298 (2002), 1424–1427.
56. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A.B., Benoist, C., Shoelson, S., Mathis, D., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15 (2009), 930–939.
57. Fontana, L., Partridge, L., Longo, V.D.D., Extending healthy life span–from yeast to humans. Science 328 (2010), 321–326.
58. Franceschi, C., Bonafè, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., De Benedictis, G., Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N Y Acad. Sci. 908 (2000), 244–254.
59. Fujita, H., Sugimoto, K., Inatomi, S., Maeda, T., Osanai, M., Uchiyama, Y., Yamamoto, Y., Wada, T., Kojima, T., Yokozaki, H., et al. Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. Mol. Biol. Cell 19 (2008), 1912–1921.
60. Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De Paepe, M., Brandi, G., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31 (2009), 677–689.
61. Ge, H., Li, X., Weiszmann, J., Wang, P., Baribault, H., Chen, J.-L., Tian, H., Li, Y., Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149 (2008), 4519–4526.
62. Goldfine, A.B., Fonseca, V., Jablonski, K.A., Pyle, L., Staten, M.A., Shoelson, S.E., TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152 (2010), 346–357.
63. Gordon, J.I., Dewey, K.G., Mills, D.A., Medzhitov, R.M., The human gut microbiota and undernutrition. Sci. Transl. Med., 4, 2012, 137ps12.
64. Green, D.R., Galluzzi, L., Kroemer, G., Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 333 (2011), 1109–1112.
65. Gutierrez, D.A., Muralidhar, S., Feyerabend, T.B., Herzig, S., Rodewald, H.-R., Hematopoietic Kit Deficiency, rather than Lack of Mast Cells, Protects Mice from Obesity and Insulin Resistance. Cell Metab. 21 (2015), 678–691.
66. Harvie, M.N., Pegington, M., Mattson, M.P., Frystyk, J., Dillon, B., Evans, G., Cuzick, J., Jebb, S.A., Martin, B., Cutler, R.G., et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int. J. Obes. 35 (2011), 714–727.
67. Hauner, H., The mode of action of thiazolidinediones. Diabetes Metab. Res. Rev. 18:Suppl 2 (2002), S10–S15.
68. Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., Thaiss, C.A., Kau, A.L., Eisenbarth, S.C., Jurczak, M.J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482 (2012), 179–185.
69. Hevener, A.L., Olefsky, J.M., Reichart, D., Nguyen, M.T.A., Bandyopadyhay, G., Leung, H.-Y., Watt, M.J., Benner, C., Febbraio, M.A., Nguyen, A.-K., et al. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J. Clin. Invest. 117 (2007), 1658–1669.
70. Hirosumi, J., Tuncman, G., Chang, L., Görgün, C.Z., Uysal, K.T., Maeda, K., Karin, M., Hotamisligil, G.S., A central role for JNK in obesity and insulin resistance. Nature 420 (2002), 333–336.
71. Hotamisligil, G.S., Inflammation and metabolic disorders. Nature 444 (2006), 860–867.
72. Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993), 87–91.
73. Howard, J.K., Lord, G.M., Matarese, G., Vendetti, S., Ghatei, M.A., Ritter, M.A., Lechler, R.I., Bloom, S.R., Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J. Clin. Invest. 104 (1999), 1051–1059.
74. Hundal, R.S., Petersen, K.F., Mayerson, A.B., Randhawa, P.S., Inzucchi, S., Shoelson, S.E., Shulman, G.I., Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest. 109 (2002), 1321–1326.
75. Ismail, A.S., Severson, K.M., Vaishnava, S., Behrendt, C.L., Yu, X., Benjamin, J.L., Ruhn, K.A., Hou, B., DeFranco, A.L., Yarovinsky, F., Hooper, L.V., Gammadelta intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc. Natl. Acad. Sci. USA 108 (2011), 8743–8748.
76. Itani, S.I., Ruderman, N.B., Schmieder, F., Boden, G., Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51 (2002), 2005–2011.
77. Johnson, A.M.F., Olefsky, J.M., The origins and drivers of insulin resistance. Cell 152 (2013), 673–684.
78. Juge-Aubry, C.E., Somm, E., Giusti, V., Pernin, A., Chicheportiche, R., Verdumo, C., Rohner-Jeanrenaud, F., Burger, D., Dayer, J.-M., Meier, C.A., Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 52 (2003), 1104–1110.
79. Karlsson, F.H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., Nielsen, J., Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun., 3, 2012, 1245.
80. Kewley, R.J., Whitelaw, M.L., Chapman-Smith, A., The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell Biol. 36 (2004), 189–204.
81. Kim, H.-J., Higashimori, T., Park, S.-Y., Choi, H., Dong, J., Kim, Y.-J., Noh, H.-L., Cho, Y.-R., Cline, G., Kim, Y.-B., Kim, J.K., Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53 (2004), 1060–1067.
82. Kim, M.H., Kang, S.G., Park, J.H., Yanagisawa, M., Kim, C.H., Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145 (2013), 396–406.e1 10.
83. Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T., Terasawa, K., Kashihara, D., Hirano, K., Tani, T., et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun., 4, 2013, 1829.
84. Kiss, E.A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C., Diefenbach, A., Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334 (2011), 1561–1565.
85. Kodama, K., Horikoshi, M., Toda, K., Yamada, S., Hara, K., Irie, J., Sirota, M., Morgan, A.A., Chen, R., Ohtsu, H., et al. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc. Natl. Acad. Sci. USA 109 (2012), 7049–7054.
86. Kollmann, T.R., Levy, O., Montgomery, R.R., Goriely, S., Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 37 (2012), 771–783.
87. Kopp, E., Ghosh, S., Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265 (1994), 956–959.
88. Koppaka, S., Kehlenbrink, S., Carey, M., Li, W., Sanchez, E., Lee, D.-E., Lee, H., Chen, J., Carrasco, E., Kishore, P., et al. Reduced adipose tissue macrophage content is associated with improved insulin sensitivity in thiazolidinedione-treated diabetic humans. Diabetes 62 (2013), 1843–1854.
89. Koren, O., Goodrich, J.K., Cullender, T.C., Spor, A., Laitinen, K., Bäckhed, H.K., Gonzalez, A., Werner, J.J., Angenent, L.T., Knight, R., et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150 (2012), 470–480.
90. Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y.S., De Vadder, F., Arora, T., Hallen, A., Martens, E., Björck, I., Bäckhed, F., Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella. Cell Metab. 22 (2015), 971–982.
91. Kumar, H., Lund, R., Laiho, A., Lundelin, K., Ley, R.E., Isolauri, E., Salminen, S., Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio 5 (2014), e02113–e02114.
92. Kusminski, C.M., McTernan, P.G., Kumar, S., Role of resistin in obesity, insulin resistance and Type II diabetes. Clin. Sci. 109 (2005), 243–256.
93. La Cava, A., Matarese, G., The weight of leptin in immunity. Nat. Rev. Immunol. 4 (2004), 371–379.
94. Lan, F., Misu, H., Chikamoto, K., Takayama, H., Kikuchi, A., Mohri, K., Takata, N., Hayashi, H., Matsuzawa-Nagata, N., Takeshita, Y., et al. LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance. Diabetes 63 (2014), 1649–1664.
95. Leibowitz, K.L., Moore, R.H., Ahima, R.S., Stunkard, A.J., Stallings, V.A., Berkowitz, R.I., Chittams, J.L., Faith, M.S., Stettler, N., Maternal obesity associated with inflammation in their children. World J. Pediatr. 8 (2012), 76–79.
96. Lesage, J., Blondeau, B., Grino, M., Bréant, B., Dupouy, J.P., Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology 142 (2001), 1692–1702.
97. Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102 (2005), 11070–11075.
98. Li, Y., Innocentin, S., Withers, D.R., Roberts, N.A., Gallagher, A.R., Grigorieva, E.F., Wilhelm, C., Veldhoen, M., Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147 (2011), 629–640.
99. Li, J., Chanda, D., Shiri-Sverdlov, R., Neumann, D., MSP: an emerging player in metabolic syndrome. Cytokine Growth Factor Rev. 26 (2015), 75–82.
100. Li, P., Oh, D.Y., Bandyopadhyay, G., Lagakos, W.S., Talukdar, S., Osborn, O., Johnson, A., Chung, H., Mayoral, R., Maris, M., et al. LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat. Med. 21 (2015), 239–247.
101. Li, Y., Oosting, M., Deelen, P., Ricaño-Ponce, I., Smeekens, S., Jaeger, M., Matzaraki, V., Swertz, M.A., Xavier, R.J., Franke, L., et al. Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi. Nat. Med. 22 (2016), 952–960.
102. Liston, A., Carr, E.J., Linterman, M.A., Shaping Variation in the Human Immune System. Trends Immunol. 37 (2016), 637–646.
103. Liu, J., Divoux, A., Sun, J., Zhang, J., Clément, K., Glickman, J.N., Sukhova, G.K., Wolters, P.J., Du, J., Gorgun, C.Z., et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 15 (2009), 940–945.
104. Longo, V.D., Mattson, M.P., Fasting: molecular mechanisms and clinical applications. Cell Metab. 19 (2014), 181–192.
105. López-Otín, C., Blasco, M.A., Partridge, L., Serrano, M., Kroemer, G., The Hallmarks of Aging. Cell 153 (2013), 1194–1217.
106. Lord, G.M., Matarese, G., Howard, J.K., Baker, R.J., Bloom, S.R., Lechler, R.I., Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 (1998), 897–901.
107. Lumeng, C.N., Saltiel, A.R., Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121 (2011), 2111–2117.
108. Lumeng, C.N., Bodzin, J.L., Saltiel, A.R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117 (2007), 175–184.
109. Lumeng, C.N., Deyoung, S.M., Bodzin, J.L., Saltiel, A.R., Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56 (2007), 16–23.
110. MacDonald, L., Hazi, A., Paolini, A.G., Kent, S., Calorie restriction dose-dependently abates lipopolysaccharide-induced fever, sickness behavior, and circulating interleukin-6 while increasing corticosterone. Brain Behav. Immun. 40 (2014), 18–26.
111. Macia, L., Tan, J., Vieira, A.T., Leach, K., Stanley, D., Luong, S., Maruya, M., Ian McKenzie, C., Hijikata, A., Wong, C., et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun., 6, 2015, 6734.
112. Macpherson, A.J., Uhr, T., Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 (2004), 1662–1665.
113. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8 (2002), 731–737.
114. Mancuso, P., Gottschalk, A., Phare, S.M., Peters-Golden, M., Lukacs, N.W., Huffnagle, G.B., Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J. Immunol. 168 (2002), 4018–4024.
115. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004), 677–686.
116. Martín-Romero, C., Sánchez-Margalet, V., Human leptin activates PI3K and MAPK pathways in human peripheral blood mononuclear cells: possible role of Sam68. Cell. Immunol. 212 (2001), 83–91.
117. Martino, D.J., Prescott, S.L., Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease. Allergy 65 (2010), 7–15.
118. Maslowski, K.M., Mackay, C.R., Diet, gut microbiota and immune responses. Nat. Immunol. 12 (2011), 5–9.
119. Masui, R., Sasaki, M., Funaki, Y., Ogasawara, N., Mizuno, M., Iida, A., Izawa, S., Kondo, Y., Ito, Y., Tamura, Y., et al. G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells. Inflamm. Bowel Dis. 19 (2013), 2848–2856.
120. Mauer, J., Chaurasia, B., Plum, L., Quast, T., Hampel, B., Blüher, M., Kolanus, W., Kahn, C.R., Brüning, J.C., Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet., 6, 2010, e1000938.
121. McKenzie, C.I., Mackay, C.R., Macia, L., GPR43 - A Prototypic Metabolite Sensor Linking Metabolic and Inflammatory Diseases. Trends Endocrinol. Metab. 26 (2015), 511–512.
122. Medzhitov, R., Origin and physiological roles of inflammation. Nature 454 (2008), 428–435.
123. Meng, Q., Cai, D., Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)/NF-kappaB pathway. J. Biol. Chem. 286 (2011), 32324–32332.
124. Misu, H., Takamura, T., Takayama, H., Hayashi, H., Matsuzawa-Nagata, N., Kurita, S., Ishikura, K., Ando, H., Takeshita, Y., Ota, T., et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab. 12 (2010), 483–495.
125. Monteiro-Sepulveda, M., Touch, S., Mendes-Sá, C., André, S., Poitou, C., Allatif, O., Cotillard, A., Fohrer-Ting, H., Hubert, E.-L., Remark, R., et al. Jejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling. Cell Metab. 22 (2015), 113–124.
126. Mouralidarane, A., Soeda, J., Visconti-Pugmire, C., Samuelsson, A.-M., Pombo, J., Maragkoudaki, X., Butt, A., Saraswati, R., Novelli, M., Fusai, G., et al. Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. Hepatology 58 (2013), 128–138.
127. Myles, I.A., Fontecilla, N.M., Janelsins, B.M., Vithayathil, P.J., Segre, J.A., Datta, S.K., Parental dietary fat intake alters offspring microbiome and immunity. J. Immunol. 191 (2013), 3200–3209.
128. Netea, M.G., Wijmenga, C., O'Neill, L.A.J., Genetic variation in Toll-like receptors and disease susceptibility. Nat. Immunol. 13 (2012), 535–542.
129. Odegaard, J.I., Ricardo-Gonzalez, R.R., Goforth, M.H., Morel, C.R., Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F., Ferrante, A.W., Chawla, A., Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447 (2007), 1116–1120.
130. Oh, D.Y., Talukdar, S., Bae, E.J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W.J., Watkins, S.M., Olefsky, J.M., GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142 (2010), 687–698.
131. Oh, D.Y., Walenta, E., Akiyama, T.E., Lagakos, W.S., Lackey, D., Pessentheiner, A.R., Sasik, R., Hah, N., Chi, T.J., Cox, J.M., et al. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat. Med. 20 (2014), 942–947.
132. Oike, Y., Akao, M., Yasunaga, K., Yamauchi, T., Morisada, T., Ito, Y., Urano, T., Kimura, Y., Kubota, Y., Maekawa, H., et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat. Med. 11 (2005), 400–408.
133. Osborn, O., Olefsky, J.M., The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18 (2012), 363–374.
134. Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A., Walsh, K., Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329 (2010), 454–457.
135. Ouwehand, A.C., Bergsma, N., Parhiala, R., Lahtinen, S., Gueimonde, M., Finne-Soveri, H., Strandberg, T., Pitkälä, K., Salminen, S., Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol. Med. Microbiol. 53 (2008), 18–25.
136. Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S.S., Bhattacharya, S., Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 18 (2012), 1279–1285.
137. Pierce, J.W., Read, M.A., Ding, H., Luscinskas, F.W., Collins, T., Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J. Immunol. 156 (1996), 3961–3969.
138. Psichas, A., Sleeth, M.L., Murphy, K.G., Brooks, L., Bewick, G.A., Hanyaloglu, A.C., Ghatei, M.A., Bloom, S.R., Frost, G., The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int. J. Obes. 39 (2015), 424–429.
139. Pulendran, B., Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc. Natl. Acad. Sci. USA 111 (2014), 12300–12306.
140. Rahman, M., Muhammad, S., Khan, M.A., Chen, H., Ridder, D.A., Müller-Fielitz, H., Pokorná, B., Vollbrandt, T., Stölting, I., Nadrowitz, R., et al. The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat. Commun., 5, 2014, 3944.
141. Reardon, S., Infections reveal inequality between the sexes. Nature, 534, 2016, 447.
142. Remely, M., Aumueller, E., Jahn, D., Hippe, B., Brath, H., Haslberger, A.G., Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity. Benef. Microbes 5 (2014), 33–43.
143. Remely, M., Aumueller, E., Merold, C., Dworzak, S., Hippe, B., Zanner, J., Pointner, A., Brath, H., Haslberger, A.G., Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 537 (2014), 85–92.
144. Rera, M., Clark, R.I., Walker, D.W., Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc. Natl. Acad. Sci. USA 109 (2012), 21528–21533.
145. Roberts, K.A., Riley, S.C., Reynolds, R.M., Barr, S., Evans, M., Statham, A., Hor, K., Jabbour, H.N., Norman, J.E., Denison, F.C., Placental structure and inflammation in pregnancies associated with obesity. Placenta 32 (2011), 247–254.
146. Rocha, D.M., Caldas, A.P., Oliveira, L.L., Bressan, J., Hermsdorff, H.H., Saturated fatty acids trigger TLR4-mediated inflammatory response. Atherosclerosis 244 (2016), 211–215.
147. Rogier, E.W., Frantz, A.L., Bruno, M.E.C., Wedlund, L., Cohen, D.A., Stromberg, A.J., Kaetzel, C.S., Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc. Natl. Acad. Sci. USA 111 (2014), 3074–3079.
148. Rönn, T., Volkov, P., Gillberg, L., Kokosar, M., Perfilyev, A., Jacobsen, A.L., Jørgensen, S.W., Brøns, C., Jansson, P.-A., Eriksson, K.-F., et al. Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood. Hum. Mol. Genet. 24 (2015), 3792–3813.
149. Rubinsztein, D.C., Mariño, G., Kroemer, G., Autophagy and aging. Cell 146 (2011), 682–695.
150. Salminen, A., Kaarniranta, K., Kauppinen, A., Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany, N.Y.) 4 (2012), 166–175.
151. Scherer, P.E., Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55 (2006), 1537–1545.
152. Schottelius, A.J., Mayo, M.W., Sartor, R.B., Baldwin, A.S. Jr., Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J. Biol. Chem. 274 (1999), 31868–31874.
153. Schwarzer, M., Makki, K., Storelli, G., Machuca-Gayet, I., Srutkova, D., Hermanova, P., Martino, M.E., Balmand, S., Hudcovic, T., Heddi, A., et al. Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science 351 (2016), 854–857.
154. Simar, D., Versteyhe, S., Donkin, I., Liu, J., Hesson, L., Nylander, V., Fossum, A., Barrès, R., DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human. Metabolism 63 (2014), 1188–1197.
155. Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P.D., Manicassamy, S., Munn, D.H., et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40 (2014), 128–139.
156. Smith, M.I., Yatsunenko, T., Manary, M.J., Trehan, I., Mkakosya, R., Cheng, J., Kau, A.L., Rich, S.S., Concannon, P., Mychaleckyj, J.C., et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339 (2013), 548–554.
157. Smith, B.K., Ford, R.J., Desjardins, E.M., Green, A.E., Hughes, M.C., Houde, V.P., Day, E.A., Marcinko, K., Crane, J.D., Mottillo, E.P., et al. Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1. Diabetes 65 (2016), 3352–3361.
158. Spencer, M., Finlin, B.S., Unal, R., Zhu, B., Morris, A.J., Shipp, L.R., Lee, J., Walton, R.G., Adu, A., Erfani, R., et al. Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes 62 (2013), 1709–1717.
159. Spite, M., Hellmann, J., Tang, Y., Mathis, S.P., Kosuri, M., Bhatnagar, A., Jala, V.R., Haribabu, B., Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity. J. Immunol. 187 (2011), 1942–1949.
160. Stanley, T.L., Zanni, M.V., Johnsen, S., Rasheed, S., Makimura, H., Lee, H., Khor, V.K., Ahima, R.S., Grinspoon, S.K., TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J. Clin. Endocrinol. Metab. 96 (2011), E146–E150.
161. Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C.A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514 (2014), 181–186.
162. Thaiss, C.A., Levy, M., Suez, J., Elinav, E., The interplay between the innate immune system and the microbiota. Curr. Opin. Immunol. 26 (2014), 41–48.
163. Thorburn, A.N., Macia, L., Mackay, C.R., Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity 40 (2014), 833–842.
164. Thorn, S.R., Baquero, K.C., Newsom, S.A., El Kasmi, K.C., Bergman, B.C., Shulman, G.I., Grove, K.L., Friedman, J.E., Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates. Diabetes 63 (2014), 2702–2713.
165. Tousoulis, D., Plastiras, A., Siasos, G., Oikonomou, E., Verveniotis, A., Kokkou, E., Maniatis, K., Gouliopoulos, N., Miliou, A., Paraskevopoulos, T., Stefanadis, C., Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome. Atherosclerosis 232 (2014), 10–16.
166. Trasande, L., Blustein, J., Liu, M., Corwin, E., Cox, L.M., Blaser, M.J., Infant antibiotic exposures and early-life body mass. Int. J. Obes. 37 (2013), 16–23.
167. Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L.P., Harris, N.L., Marsland, B.J., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20 (2014), 159–166.
168. Tsang, J.S., Schwartzberg, P.L., Kotliarov, Y., Biancotto, A., Xie, Z., Germain, R.N., Wang, E., Olnes, M.J., Narayanan, M., Golding, H., et al. Baylor HIPC Center, CHI Consortium. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 157 (2014), 499–513.
169. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
170. Turnbaugh, P.J., Bäckhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
171. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
172. Uysal, K.T., Wiesbrock, S.M., Marino, M.W., Hotamisligil, G.S., Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997), 610–614.
173. Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J.E., Stadler, K., Mynatt, R.L., Ravussin, E., Stephens, J.M., Dixit, V.D., The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17 (2011), 179–188.
174. Vernia, S., Cavanagh-Kyros, J., Barrett, T., Tournier, C., Davis, R.J., Fibroblast Growth Factor 21 Mediates Glycemic Regulation by Hepatic JNK. Cell Rep. 14 (2016), 2273–2280.
175. Versini, M., Jeandel, P.-Y., Rosenthal, E., Shoenfeld, Y., Obesity in autoimmune diseases: not a passive bystander. Autoimmun. Rev. 13 (2014), 981–1000.
176. Vinolo, M.A.R., Ferguson, G.J., Kulkarni, S., Damoulakis, G., Anderson, K., Bohlooly-Y, M., Stephens, L., Hawkins, P.T., Curi, R., SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS ONE, 6, 2011, e21205.
177. Voight, B.F., Scott, L.J., Steinthorsdottir, V., Morris, A.P., Dina, C., Welch, R.P., Zeggini, E., Huth, C., Aulchenko, Y.S., Thorleifsson, G., et al. MAGIC investigators, GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42 (2010), 579–589.
178. Wacklin, P., Tuimala, J., Nikkilä, J., Sebastian Tims, Mäkivuokko, H., Alakulppi, N., Laine, P., Rajilic-Stojanovic, M., Paulin, L., de Vos, W.M., Mättö, J., Faecal microbiota composition in adults is associated with the FUT2 gene determining the secretor status. PLoS ONE, 9, 2014, e94863.
179. Wahl, S., Drong, A., Lehne, B., Loh, M., Scott, W.R., Kunze, S., Tsai, P.-C., Ried, J.S., Zhang, W., Yang, Y., et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature 541 (2017), 81–86.
180. Walder, K., Kantham, L., McMillan, J.S., Trevaskis, J., Kerr, L., De Silva, A., Sunderland, T., Godde, N., Gao, Y., Bishara, N., et al. Tanis: a link between type 2 diabetes and inflammation?. Diabetes 51 (2002), 1859–1866.
181. Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., Feldstein, A.E., Britt, E.B., Fu, X., Chung, Y.-M., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
182. Wang, X., Ota, N., Manzanillo, P., Kates, L., Zavala-Solorio, J., Eidenschenk, C., Zhang, J., Lesch, J., Lee, W.P., Ross, J., et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514 (2014), 237–241.
183. Waterland, R.A., Michels, K.B., Epigenetic epidemiology of the developmental origins hypothesis. Annu. Rev. Nutr. 27 (2007), 363–388.
184. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., Ferrante, A.W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003), 1796–1808.
185. Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M.T.-H., Brickey, W.J., Ting, J.P.-Y., Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12 (2011), 408–415.
186. Wensveen, F.M., Jelenčić, V., Valentić, S., Šestan, M., Wensveen, T.T., Theurich, S., Glasner, A., Mendrila, D., Štimac, D., Wunderlich, F.T., et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol. 16 (2015), 376–385.
187. Wesolowski, S.R., Kasmi, K.C., Jonscher, K.R., Friedman, J.E., Developmental origins of NAFLD: a womb with a clue. Nat. Rev. Gastroenterol. Hepatol. 14 (2017), 81–96.
188. Williamson, R.T., On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate. BMJ 1 (1901), 760–762.
189. Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mastronardi, F., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15 (2009), 921–929.
190. Winer, D.A., Winer, S., Shen, L., Wadia, P.P., Yantha, J., Paltser, G., Tsui, H., Wu, P., Davidson, M.G., Alonso, M.N., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17 (2011), 610–617.
191. Wolf, A.M., Wolf, D., Rumpold, H., Enrich, B., Tilg, H., Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem. Biophys. Res. Commun. 323 (2004), 630–635.
192. Wu, D., Molofsky, A.B., Liang, H.-E., Ricardo-Gonzalez, R.R., Jouihan, H.A., Bando, J.K., Chawla, A., Locksley, R.M., Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332 (2011), 243–247.
193. Xiong, Y., Miyamoto, N., Shibata, K., Valasek, M.A., Motoike, T., Kedzierski, R.M., Yanagisawa, M., Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. USA 101 (2004), 1045–1050.
194. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., Chen, H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003), 1821–1830.
195. Yang, L., Roh, Y.S., Song, J., Zhang, B., Liu, C., Loomba, R., Seki, E., Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology 59 (2014), 483–495.
196. Yang, X., Wang, X., Liu, D., Yu, L., Xue, B., Shi, H., Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b. Mol. Endocrinol. 28 (2014), 565–574.
197. Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A.J., Tomiyama, Y., Matsuzawa, Y., Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000), 1723–1732.
198. Youm, Y.-H., Grant, R.W., McCabe, L.R., Albarado, D.C., Nguyen, K.Y., Ravussin, A., Pistell, P., Newman, S., Carter, R., Laque, A., et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 18 (2013), 519–532.
199. Youm, Y.-H., Nguyen, K.Y., Grant, R.W., Goldberg, E.L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T.D., et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21 (2015), 263–269.
200. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.W., Karin, M., Shoelson, S.E., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293 (2001), 1673–1677.
201. Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell 163 (2015), 1079–1094.
202. Zhang, C., Li, S., Yang, L., Huang, P., Li, W., Wang, S., Zhao, G., Zhang, M., Pang, X., Yan, Z., et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat. Commun., 4, 2013, 2163.
203. Zhang, Z., Li, J., Zheng, W., Zhao, G., Zhang, H., Wang, X., Guo, Y., Qin, C., Shi, Y., Peripheral Lymphoid Volume Expansion and Maintenance Are Controlled by Gut Microbiota via RALDH+ Dendritic Cells. Immunity 44 (2016), 330–342.